OncoMyx Therapeutics, Inc. — Form D
OncoMyx Therapeutics, Inc. of PHOENIX, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-13. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-13
- Form: D
- Accession: 0001779436-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 13
- Date of first sale: 2021-11-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-424596
Issuer
- Name: OncoMyx Therapeutics, Inc.
- CIK: 0001779436
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 850 N. 5th St., Ste. 402, PHOENIX, AZ, 85004
- Phone: (602) 567-8064
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Charles M Baum, M.D., Ph.D. | Director | Phoenix, AZ |
| Kanad J Das, Ph.D. | Director | Phoenix, AZ |
| Widya J Mulyasasmita, Ph.D. | Director | Phoenix, AZ |
| Steven J Potts, Ph.D. | Director | Phoenix, AZ |
| Benjamin J Rovinski, Ph.D. | Director | Phoenix, AZ |
| Ting J Xiao, C.F.A., F.R.M. | Director | Phoenix, AZ |
| Steven J Potts, Ph.D. | Executive Officer | Phoenix, AZ |
| Leslie M Sharp, Ph.D. | Executive Officer | Phoenix, AZ |
| Ting G Xiao | Director | Phoenix, AZ |
| Jason G Rushton | Director | Phoenix, AZ |
| Douglas Grant McFadden, Ph.D. | Director | Phoenix, AZ |
| Kanad G Das, Ph.D. | Director | Phoenix, AZ |
| Michael G Wood | Executive Officer | Phoenix, AZ |
Other filings by this issuer (1)
More